珠海润都制药股份有限公司 关于布洛芬片获得药品注册证书的公告

Group 1 - The company has received a drug registration certificate from the National Medical Products Administration for Ibuprofen Tablets, which will be classified as a Class A over-the-counter drug [1][3]. - The drug is indicated for the relief of mild to moderate pain such as headaches, joint pain, migraines, toothaches, muscle pain, neuralgia, and dysmenorrhea, as well as for fever caused by common colds or influenza [2]. - The approval of Ibuprofen Tablets enhances the company's analgesic product line, potentially benefiting more patients and expanding market sales, which is expected to have a positive impact on the company's operating performance [3]. Group 2 - The company emphasizes the importance of drug research and development, maintaining strict quality and safety controls throughout the drug development, manufacturing, and sales processes [3]. - Future market sales of the product may be influenced by various uncertain factors, including policy environment and market changes [3].